Home › Mead Johnson Nutrition CO (MJN) Cut to Sell at Zacks Investment Research
 

Keywords :   


Mead Johnson Nutrition CO (MJN) Cut to Sell at Zacks Investment Research

2016-01-10 00:47:53| Biotech - Topix.net

According to Zacks, "Mead Johnson posted dismal financial numbers in the third quarter of 2015, missing the Zacks Consensus Estimate of both earnings and revenues.The company's segmental performance was also considerably weak. Moreover, the near-term challenges in its emerging market segments are expected to continue in 2016 as well.

Tags: research sell cut investment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.11Ahlstroms Climate Targets Validated by SBTi
07.11Mativ Reports Third Quarter Results
07.11Lawsuit over FDA's regulatory approval process for carbadox dismissed
07.11Hurricane Rafael Graphics
07.11Hurricane Rafael Forecast Discussion Number 16
07.11Hurricane Rafael Wind Speed Probabilities Number 16
07.11Hurricane Rafael Forecast Advisory Number 16
07.11Hurricane Rafael Public Advisory Number 16
More »